Natural compounds as antiatherogenic agents

Uzma Saqib1, Masood A Khan2, Manikandan Alagumuthu3

  • 1Discipline of Chemistry, Indian Institute of Technology Indore (IITI), Simrol, Indore, India. suraj.parihar@uct.ac.za.

Insights

This review explores plant-based natural compounds that can modulate atherosclerosis (AS), a major cause of heart disease. These compounds offer potential therapeutic strategies by targeting key mechanisms in AS progression.

Area of Science:

  • Cardiovascular Science
  • Pharmacology
  • Natural Product Chemistry

Background:

  • Atherosclerosis (AS) is a primary cause of global mortality, linked to coronary heart disease (CHD) and cardiovascular diseases (CVDs).
  • AS pathogenesis involves cholesterol accumulation in macrophages, forming foam cells, driven by oxidized low-density lipoprotein (LDL) influx and impaired cholesterol efflux.
  • Natural compounds have a long history in AS treatment and prevention, with growing interest in medicinal herbs.

Purpose of the Study:

  • To review plant-based natural compounds with potential as atherosclerosis modulators.
  • To elucidate the underlying mechanisms of action for these natural compounds in AS.
  • To highlight potential therapeutic implications of these findings for AS treatment.

Main Methods:

  • Comprehensive literature search for studies on plant-derived compounds and atherosclerosis.
  • Analysis of reported mechanisms of action for identified natural compounds.
  • Synthesis of information on therapeutic potential and future research directions.

Main Results:

  • Numerous plant-based natural compounds have demonstrated efficacy in modulating AS.
  • Mechanisms include influencing lipid metabolism, anti-inflammatory effects, and antioxidant properties.
  • These compounds target key pathways in foam cell formation and plaque development.

Conclusions:

  • Plant-derived natural compounds represent a promising avenue for AS therapeutic development.
  • Understanding their mechanisms provides a basis for novel treatment strategies.
  • Further research is warranted to translate these findings into clinical applications for cardiovascular health.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
946
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
5.5K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
842
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
735
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
777